Page results
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
Outcome of National Institute for Health and Care Excellence (NICE) Technology Appraisal for Exagamglogene autotemcel (Exa-cel) for treating transfusion- dependent beta thalassaemia [ID4015] in individuals 12 years and over.
-
A team of clinician scientists at UCLH have identified the factors which predict full hearing recovery, with the strongest predictor being treatment with steroids within seven days of a sudden drop in hearing.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy). We provide multidisciplinary care for patients who are referred from their GP or from other hospitals. Although immune-related neurotoxicity is relatively rare it may be severe and is associated with significant disability and high risk to patients if not recognised and managed promptly and well.
-
EMIS outage caused backlog of result messages via Keystone
-
Contact phone and email numbers for University College London Hospitals NHS Foundation Trust.
-
This page provides information about the Palliative care and symptom control team
-
Contact details of clinical lead adults and lead paediatrics
-
This patient information explains an inguinal gonadectomy.
-
This patient information explains laparoscopic gonadectomy.
File results
-
FOI/2023/0125 - Staffing rota/ planning to support working parents
-
FOI/2023/0131 - Training for first aid, life support, CPR and resuscitation/ defibrillator
-
FOI/2023/0146 - Total bed management contract with Medstrom
-
FOI/2023/0159 - Local treatment guidelines for Atopic Dermatitis (Atopic Eczema)
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0188 - Payments to suppliers
-
FOI/2023/0202 - Nitrous oxide/ Entonox personal sampling for staff
-
FOI/2023/0203 - Maintenance contract(s) for flexible endoscope inventory
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0211 - Services available to older residents